Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas C P Cross

Showing results (51-60 of 221) with videos related to

Pageof 23
Sort By:
Nucleic Acid Therapeutics|September 23, 2016
Antisense Oligonucleotides Modulating Activation of a Nonsense-Mediated RNA Decay Switch Exon in the ATM GeneJana Kralovicova, Pedro M D Moreno, Nicholas C P Cross, et al.
British Journal of Haematology|May 27, 2009
Acute myeloid leukaemia with associated eosinophilia: justification for FIP1L1-PDGFRA screening in cases lacking the CBFB-MYH11 fusion geneYoussef Sorour, Christopher D Dalley, John A Snowden, et al.
Experimental Hematology|September 4, 2007
A constitutively active SPTBN1-FLT3 fusion in atypical chronic myeloid leukemia is sensitive to tyrosine kinase inhibitors and immunotherapyFrancis H Grand, Sameena Iqbal, Lingyan Zhang, et al.
Blood Advances|September 6, 2023
Should we move to a genomic classification of neutrophilic myeloid neoplasms?Gonzalo Carreño-Tarragona, Alberto Álvarez-Larrán, Juan Carlos Hernández-Boluda, et al.
Haematologica|August 14, 2008
Rapid identification of JAK2 exon 12 mutations using high resolution melting analysisAmy V Jones, Nicholas C P Cross, Helen E White, et al.
Leukemia Research|January 7, 2019
Molecular response to imatinib in KIT F522C-mutated systemic mastocytosisValerie Broderick, Katherine Waghorn, Stephen E Langabeer, et al.
Haematologica|October 13, 2004
Lack of response to imatinib mesylate in a patient with accelerated phase myeloproliferative disorder with rearrangement of the platelet-derived growth factor receptor beta-geneJean-Noël Bastie, Isabel Garcia, Christine Terré, et al.
American Journal of Hematology|February 24, 2018
Chronic neutrophilic leukemiaAhmad Khoder, Magda Al Obaidi, Anna Babb, et al.
Annals of Hematology|June 18, 2010
The myeloproliferative neoplasm-associated JAK2 46/1 haplotype is not overrepresented in chronic myelogenous leukemiaAmbra Spolverini, Amy V Jones, Andreas Hochhaus, et al.
Blood|May 14, 2010
In search of the original leukemic clone in chronic myeloid leukemia patients in complete molecular remission after stem cell transplantation or imatinibManuel Sobrinho-Simões, Vicki Wilczek, Joannah Score, et al.
Pageof 23

Showing results (51-60 of 221) with videos related to

Sort By:
Pageof 23
Nucleic Acid Therapeutics|September 23, 2016
Antisense Oligonucleotides Modulating Activation of a Nonsense-Mediated RNA Decay Switch Exon in the ATM GeneJana Kralovicova, Pedro M D Moreno, Nicholas C P Cross, et al.
British Journal of Haematology|May 27, 2009
Acute myeloid leukaemia with associated eosinophilia: justification for FIP1L1-PDGFRA screening in cases lacking the CBFB-MYH11 fusion geneYoussef Sorour, Christopher D Dalley, John A Snowden, et al.
Experimental Hematology|September 4, 2007
A constitutively active SPTBN1-FLT3 fusion in atypical chronic myeloid leukemia is sensitive to tyrosine kinase inhibitors and immunotherapyFrancis H Grand, Sameena Iqbal, Lingyan Zhang, et al.
Blood Advances|September 6, 2023
Should we move to a genomic classification of neutrophilic myeloid neoplasms?Gonzalo Carreño-Tarragona, Alberto Álvarez-Larrán, Juan Carlos Hernández-Boluda, et al.
Haematologica|August 14, 2008
Rapid identification of JAK2 exon 12 mutations using high resolution melting analysisAmy V Jones, Nicholas C P Cross, Helen E White, et al.
Leukemia Research|January 7, 2019
Molecular response to imatinib in KIT F522C-mutated systemic mastocytosisValerie Broderick, Katherine Waghorn, Stephen E Langabeer, et al.
Haematologica|October 13, 2004
Lack of response to imatinib mesylate in a patient with accelerated phase myeloproliferative disorder with rearrangement of the platelet-derived growth factor receptor beta-geneJean-Noël Bastie, Isabel Garcia, Christine Terré, et al.
American Journal of Hematology|February 24, 2018
Chronic neutrophilic leukemiaAhmad Khoder, Magda Al Obaidi, Anna Babb, et al.
Annals of Hematology|June 18, 2010
The myeloproliferative neoplasm-associated JAK2 46/1 haplotype is not overrepresented in chronic myelogenous leukemiaAmbra Spolverini, Amy V Jones, Andreas Hochhaus, et al.
Blood|May 14, 2010
In search of the original leukemic clone in chronic myeloid leukemia patients in complete molecular remission after stem cell transplantation or imatinibManuel Sobrinho-Simões, Vicki Wilczek, Joannah Score, et al.
Pageof 23